We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Near-Patient Molecular Test Outperforms Other Rapid Measures for Sepsis Diagnosis

By HospiMedica International staff writers
Posted on 22 Mar 2023
Print article
Image: SeptiCyte RAPID offers a revolutionary way to diagnose sepsis (Photo courtesy of Immunexpress)
Image: SeptiCyte RAPID offers a revolutionary way to diagnose sepsis (Photo courtesy of Immunexpress)

Sepsis is a life-threatening condition that can lead to organ failure and death, causing high in-patient costs for hospitals. Detecting sepsis early is crucial, and a quick sepsis test can make a significant difference between life and death. Overuse of antibiotics can also result in new health issues and antibiotic resistance among at-risk patient populations. Thus, early detection can help health professionals determine the most effective treatment plan quickly, including potential ICU admission. However, conventional blood tests for sepsis based on microbiological culture are not reliable or speedy enough. Now, a PCR-based test for sepsis has demonstrated that it can more accurately determine if an ICU patient has sepsis as compared to other rapid diagnostic methods.

SeptiCyte RAPID from Immunexpress (Brisbane, Australia) is a sample-to-answer, cartridge-based, host response molecular test for sepsis that uses reverse transcription polymerase chain reaction (RT-PCR) to quantify the relative expression levels of host response genes isolated from whole blood. SeptiCyte RAPID is utilized alongside clinical assessments, vital signs and laboratory findings to help distinguish infection-positive (sepsis) from infection-negative systemic inflammation response syndromes in patients with organ dysfunction and high infection risk. SeptiCyte RAPID generates a score (SeptiScore) that falls within four discrete interpretation bands depending upon the increasing possibility of sepsis.

In a new study, SeptiCyte RAPID proved more accurate in determining sepsis in ICU patients than other rapid diagnostic methods, including quick Sequential Organ Failure Assessment (qSOFA). SeptiCyte RAPID in conjunction with qSOFA was statistically significant at distinguishing higher as well as lower mortality sepsis patients in the ICU cases from those without sepsis and could act as the first step in diagnostic pathways for sepsis. For the study, the researchers utilized retrospective and prospective data from clinical trials involving 419 critically ill patients with systemic inflammatory response syndrome who had been admitted to the ICU for suspicion of having sepsis. A panel of three clinicians performing expert diagnosis classified the patients as sepsis positive, sepsis negative or indeterminate, and calculated a full qSOFA score for 173 patients.

SeptiCyte RAPID distinguished between sepsis positive patients and sepsis negative patients regardless of qSOFA stratification (AUC 0.82 in qSOFA ≥2, AUC 0.81 in qSOFA < 2) and also outperformed several conventional rapid diagnosis methods such as SOFA, lactate, PCT, among other parameters. Additionally, SeptiCyte RAPID outperformed other sepsis markers in differentiating higher and lower mortality ICU cases from patients that did not have sepsis. SeptiCyte RAPID is intended for in-vitro diagnostic use and runs on the Biocartis Idylla Platform. SeptiCyte RAPID is CE Marked as a near-patient sample-to-answer test in European Union (EU) member countries and those harmonized with the EU IVD Directive (98/79/EC). As of November 2021, the test has been markers FDA cleared for use in hospitalized patients suspected of sepsis.

"This study demonstrates that SeptiCyte RAPID is not only a more accurate sepsis diagnostic tool compared to other conventional rapid diagnosis methods but can serve as a crucial first step in the diagnostic and treatment paradigm for patients suspected of sepsis using the Sepsis-3 framework. While conventional sepsis diagnosis is based on parameters such as qSOFA, PCT, lactate, white cell count, respiratory rate and temperature, SeptiCyte RAPID measures the mRNA expression of two genes that are specific to sepsis," commented Dr. Richard Brandon, Chief Scientific Officer of Immunexpress. "Emergency medicine outcomes rely on quick decision-making and action. SeptiCyte RAPID is uniquely positioned to provide clinicians in this field with actionable results in less than an hour and may be utilized early in the diagnostic pathway to determine the likelihood of sepsis. In conjunction with additional parameters of qSOFA and SOFA scores, SeptiCyte RAPID may aid clinicians in predicting the likelihood of septic shock or other unwanted health outcomes."

Related Links:

Gold Supplier
Creatinine Meter
StatSensor Xpress Creatinine Meter
Digital Ultrasound Scanner
PL-3018I 3D
Electric Gynecological Operating Table
IV Medication Safety Software
ICU Medical MedNet IV

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Surgical Techniques

view channel
Image: The deployable electrodes are ideal for minimally invasive craniosurgery (Photo courtesy of EPFL)

Soft Robotic Electrode Offers Minimally Invasive Solution for Craniosurgery

Minimally invasive medical procedures offer numerous benefits to patients, including decreased tissue damage and shorter recovery periods. However, creating equipment that can pass through a small opening... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.